Scientific Research and Development

The Scientific Research and Development team at Biocon Biologics focuses on pioneering and advancing the company’s portfolio of biosimilar molecules. This team undertakes comprehensive research activities, drives the development of new biosimilars, and oversees clinical trials to ensure safety and efficacy. They collaborate with regulatory affairs to secure approvals in global markets and work on optimizing upstream and downstream manufacturing processes. Their efforts aim to accelerate the availability of affordable biologics treatments for diseases such as diabetes, oncology, and immunology.